When the founders of Love CBD, Phil and Dan Culbertson, saw the success of CBD oil in the USA, they saw an opportunity for launching a CBD business in the UK. This family-run business from Newmarket, Suffolk, realised that many of the CBD oils available in the UK at that time (in 2014) were of substandard quality and decided to become CBD connoisseurs and put together blends with what they considered to be the best hemp strains out there.
Based on fluoride’s anti-thyroid effects in hyperthyroid patients, concerns have arisen about whether current fluoride exposures could be contributing to the increased prevalence of under-active thyroid (clinical and/or subclinical hypothyroidism) in the United States and other nations. In February 2015, British scientists reported that fluoridated water in Britain is associated with elevated rates of hypothyroidism:”
Aura CBD oil actually comes from a well-known and respected brand based in California, but it has a strong presence in the UK with a London office, and currently ships to residential addresses throughout the United Kingdom. Over the last year or so the brand has taken big steps to cement their presence on the UK CBD market, and is now offering high-potency hemp pastes, CBD edibles, and CBD skincare products in addition to their range of top-class CBD tinctures.
If you are new to CBD oil then it is probably extremely confusing. How much to take? Which UK brand is best? and where to purchase CBD from? While we tend not to play favourites, Provacan was voted the best CBD brand, providing a quality product. Not only does the company feel that they have managed to help thousands of people, but their customer support and product is top of the range. Check them out to see what we are talking about.
Currently, the only CBD product approved by the Food and Drug Administration is a prescription oil called Epidiolex. It's approved to treat two types of epilepsy. Aside from Epidiolex, state laws on the use of CBD vary. While CBD is being studied as a treatment for a wide range of conditions, including Parkinson's disease, schizophrenia, diabetes, multiple sclerosis and anxiety, research supporting the drug's benefits is still limited.